* SI-BONE Inc SIBN.OQ reported a quarterly adjusted loss
of 22
cents per share for the quarter ended in January, higher than
the same quarter last year, when the company reported EPS of -30
cents. The mean expectation of nine analysts for the quarter
was for a loss of 28 cents per share. Wall Street expected
results to range from -30 cents to -24 cents per share.
* Revenue rose 20% to $39.97 million from a year ago;
analysts
expected $38.32 million.
* SI-BONE Inc's reported EPS for the quarter was a loss
of 22
cents.
* The company reported a quarterly loss of $8.94 million.
* SI-BONE Inc shares had risen by 14.1% this quarter and
lost 29.7% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by
about 1.7%
in the last three months.
* In the last 30 days, one analyst negatively revised an
earnings
estimate
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 9 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "buy"
Wall Street's median 12-month price target for SI-BONE Inc is
$25.00
This summary was machine generated from LSEG data August 5 at
09:54 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Jun. 30 2024 -0.28 -0.22 Beat
Mar. 31 2024 -0.31 -0.27 Beat
Dec. 31 2023 -0.28 -0.27 Beat
Sep. 30 2023 -0.34 -0.25 Beat